Physician

Marc F Goldstein, M.D.

According to 2025 Medicare claims, Marc Goldstein, M.D. (NPI: 1093863334) practices allergy/immunology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is ALLERGIC DISEASE ASSOCIATES PC (NPI: 1710033477; TIN: 22-3040614) and primary practice location at 19107-1553.

Goldstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 389 traditional Medicare patients, billed 37,017 HCPCS/CPT codes, and received $840,502 in Medicare payments. The top billing code was 94726 (Test to determine lung volumes using sensors). Part D data shows 1,776 prescription claims across 339 beneficiaries totaling $1,241,052 in drug costs, led by Privigen (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 762 claims. Open Payments data shows 225 records totaling $3,878. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $422,907 to $840,502. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $304,388 and ending at $1,241,052. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,511 and ending at $32,221.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	396	18,310	$422,907
2016	391	17,816	$422,941
2017	434	17,598	$428,156
2018	431	19,348	$467,510
2019	371	16,110	$423,749
2020	368	17,793	$457,570
2021	374	20,038	$545,518
2022	371	23,651	$621,194
2023	385	27,441	$712,267
2024	389	37,017	$840,502

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	259	1,280	$304,388
2016	252	1,152	$390,790
2017	269	1,308	$843,194
2018	273	1,439	$1,313,649
2019	263	1,401	$1,762,495
2020	274	1,367	$805,169
2021	256	1,266	$820,180
2022	297	1,463	$942,535
2023	336	1,735	$1,193,235
2024	339	1,776	$1,241,052

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	119	404	$119,883
2016	144	539	$153,314
2017	107	416	$82,120
2018	119	482	$181,397
2019	95	411	$427,843
2020	96	439	$582,717
2021	68	398	$492,055
2022	102	464	$450,947
2023	115	633	$627,462
2024	136	762	$665,128

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
94726	Test to determine lung volumes using sensors	216	220	$46
94060	Test to measure expiratory airflow and volume changes before and after medication administration	215	217	$32
94375	Test to measure rate of airflow	252	669	$32
95012	Test to measure the level of nitric oxide gas	275	648	$16
94664	Evaluation of use of breathing device	266	483	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	40	1,120	$283,713
Dupixent Syringe	Dupilumab	34	1,456	$190,755
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	183	9,180	$190,533
Gammaplex	Immun Glob G(Igg)/Gly/Iga 0-50	13	390	$165,495
Gammaked	Immune Globul G/Gly/Iga Avg 46	14	392	$109,814

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1556	Injection, immune globulin (bivigam), 500 mg	N	N/R	62	$330,732
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	25	$102,147
J1557	Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	26	$84,969
J1551	Injection, immune globulin (cutaquig), 100 mg	N	N/R	13	$71,780
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	109	$36,591

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	225	$3,878	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Marc F. Goldstein, M.D.?

Tedicare shows public-source Medicare data for Marc F. Goldstein, M.D. (NPI 1093863334), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marc F. Goldstein, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marc F. Goldstein, M.D.?

Marc F. Goldstein, M.D. is linked to ALLERGIC DISEASE ASSOCIATES PC (billing NPI 1710033477) in the available physician profile data.

Does Marc F. Goldstein, M.D. have Open Payments data?

Marc F. Goldstein, M.D. has 225 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.